Roberto Cacciaglia

A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers

Carolina L. Haass‐Koffler, Kimberly Goodyear, Victoria M. Long et al. · European Journal of Pharmaceutical Sciences · 2017 · 25 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Anti-Alcohol and Anxiolytic Properties of a New Chemical Entity, GET73

Antonella Loche, F. Simonetti, Carla Lobina et al. · Frontiers in Psychiatry · 2012 · 21 citations · Full text

Medicine, Neuroscience, Pharmacology +17

GET73 Prevents Ethanol-Induced Neurotoxicity in Primary Cultures of Rat Hippocampal Neurons

Maria Cristina Tomasini, Andrea Celeste Borelli, Sarah Beggiato et al. · Alcohol and Alcoholism · 2015 · 18 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial

Julien Guiraud, Giovanni Addolorato, Henri‐Jean Aubin et al. · Journal of Psychopharmacology · 2022 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Administration of the metabotropic glutamate receptor subtype 5 allosteric modulator GET 73 with alcohol: A translational study in rats and humans

Carolina L. Haass‐Koffler, Kimberly Goodyear, Antonella Loche et al. · Journal of Psychopharmacology · 2018 · 13 citations · Full text

Medicine, Neuroscience, Pharmacology +17